A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Omnicell, Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 23,700 shares of OMCL stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,700
Previous 46,400 48.92%
Holding current value
$1.08 Million
Previous $1.26 Million 17.75%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.61 - $45.43 $581,347 - $1.03 Million
-22,700 Reduced 48.92%
23,700 $1.03 Million
Q2 2024

Aug 14, 2024

BUY
$26.22 - $32.65 $159,942 - $199,165
6,100 Added 15.14%
46,400 $1.26 Million
Q1 2024

May 15, 2024

BUY
$26.15 - $37.33 $400,095 - $571,149
15,300 Added 61.2%
40,300 $1.18 Million
Q4 2023

Feb 14, 2024

BUY
$29.24 - $45.81 $283,628 - $444,357
9,700 Added 63.4%
25,000 $940,000
Q3 2023

Nov 14, 2023

BUY
$44.6 - $73.38 $682,380 - $1.12 Million
15,300 New
15,300 $689,000
Q1 2023

May 15, 2023

SELL
$51.51 - $60.43 $1.42 Million - $1.66 Million
-27,500 Reduced 44.14%
34,800 $2.04 Million
Q4 2022

Feb 14, 2023

BUY
$46.24 - $90.03 $2.52 Million - $4.9 Million
54,400 Added 688.61%
62,300 $3.14 Million
Q3 2022

Nov 14, 2022

BUY
$84.23 - $117.38 $665,417 - $927,302
7,900 New
7,900 $688,000
Q1 2022

May 16, 2022

SELL
$120.68 - $180.51 $470,652 - $703,989
-3,900 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$153.26 - $183.62 $1.12 Million - $1.34 Million
-7,300 Reduced 65.18%
3,900 $704,000
Q3 2021

Nov 15, 2021

BUY
$141.84 - $160.88 $808,488 - $917,016
5,700 Added 103.64%
11,200 $1.66 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $151.45 $480,667 - $560,365
3,700 Added 205.56%
5,500 $833,000
Q1 2021

May 17, 2021

BUY
$117.78 - $143.9 $212,004 - $259,020
1,800 New
1,800 $234,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $2.02B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.